Protein tyrosine kinase inhibitors in cancer treatment

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.7, Iss.6, 1997-06, pp. : 571-588

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosine kinase inhibitors in cancer treatment (Part II)

By Traxler P.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. : 1599-1625

Informa Healthcare

Access to resources Recommend Favorite

Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer

Current Drug Targets, Vol. 10, Iss. 6, 2009-06 ,pp. : 575-576

Bentham Science Publishers

Access to resources Recommend Favorite

New retinoids and protein tyrosine kinase inhibitors for the treatment of disseminated cancer: selective induction of apoptosis in malignant cells

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 10, 1998-10 ,pp. : 1369-1374

Informa Healthcare

Access to resources Recommend Favorite

Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment

Current Cancer Drug Targets, Vol. 16, Iss. 2, 2016-02 ,pp. : 175-185

Bentham Science Publishers

Access to resources Recommend Favorite

Protein tyrosine kinase inhibitors as anticancer agents

By Supuran Claudiu T Scozzafava Andrea

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 35-53

Informa Healthcare

Access to resources Recommend Favorite